Bhathena A - Search Results

1

Aromatic hydrocarbon receptor expression and function in liver of hypophysectomized male rats.

Timsit YE, Chia FS, Bhathena A, Riddick DS. Timsit YE, et al. Among authors: bhathena a. Toxicol Appl Pharmacol. 2002 Dec 1;185(2):136-45. doi: 10.1006/taap.2002.9526. Toxicol Appl Pharmacol. 2002. PMID: 12490138

2

Suppression of cytochrome P450 2C11 by aromatic hydrocarbons: mechanistic insights from studies of the 5'-flanking region of the CYP2C11 gene.

Bhathena A, Lee C, Riddick DS. Bhathena A, et al. Drug Metab Dispos. 2002 Dec;30(12):1385-92. doi: 10.1124/dmd.30.12.1385. Drug Metab Dispos. 2002. PMID: 12433808

3

The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons.

Riddick DS, Lee C, Bhathena A, Timsit YE. Riddick DS, et al. Among authors: bhathena a. Can J Physiol Pharmacol. 2003 Jan;81(1):59-77. doi: 10.1139/y03-003. Can J Physiol Pharmacol. 2003. PMID: 12665258 Review.

4

Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals.

Riddick DS, Lee C, Bhathena A, Timsit YE, Cheng PY, Morgan ET, Prough RA, Ripp SL, Miller KK, Jahan A, Chiang JY. Riddick DS, et al. Among authors: bhathena a. Drug Metab Dispos. 2004 Apr;32(4):367-75. doi: 10.1124/dmd.32.4.367. Drug Metab Dispos. 2004. PMID: 15039287 Review.

5

Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.

Wang K, Ramji S, Bhathena A, Lee C, Riddick DS. Wang K, et al. Among authors: bhathena a. Xenobiotica. 1999 Feb;29(2):155-70. doi: 10.1080/004982599238713. Xenobiotica. 1999. PMID: 10199592

6

Frequency of the frame-shifting CYP2D7 138delT polymorphism in a large, ethnically diverse sample population.

Bhathena A, Mueller T, Grimm DR, Idler K, Tsurutani A, Spear BB, Katz DA. Bhathena A, et al. Drug Metab Dispos. 2007 Aug;35(8):1251-3. doi: 10.1124/dmd.107.014993. Epub 2007 May 9. Drug Metab Dispos. 2007. PMID: 17494644

7

Pharmacogenetics: improving drug and dose selection.

Bhathena A, Spear BB. Bhathena A, et al. Curr Opin Pharmacol. 2008 Oct;8(5):639-46. doi: 10.1016/j.coph.2008.07.013. Epub 2008 Sep 26. Curr Opin Pharmacol. 2008. PMID: 18762278 Review.

8

Overview of pharmacogenetics.

Katz DA, Bhathena A. Katz DA, et al. Among authors: bhathena a. Curr Protoc Hum Genet. 2009 Jan;Chapter 9:Unit 9.19. doi: 10.1002/0471142905.hg0919s60. Curr Protoc Hum Genet. 2009. PMID: 19170034 Review.

9

Defining drug disposition determinants: a pharmacogenetic-pharmacokinetic strategy.

Katz DA, Murray B, Bhathena A, Sahelijo L. Katz DA, et al. Among authors: bhathena a. Nat Rev Drug Discov. 2008 Apr;7(4):293-305. doi: 10.1038/nrd2486. Nat Rev Drug Discov. 2008. PMID: 18382463

10

Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response.

Bhathena A, Wang Y, Kraft JB, Idler KB, Abel SJ, Holley-Shanks RR, Robieson WZ, Spear B, Redden L, Katz DA. Bhathena A, et al. Transl Psychiatry. 2013 Apr 9;3(4):e245. doi: 10.1038/tp.2013.22. Transl Psychiatry. 2013. PMID: 23571810 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page